Bone Solutions’ Mg OSTEOCRETE and Mg OSTEOINJECT Receive FDA Clearance for Pediatric Use in Patients Aged Six and Older
Bone Solutions Inc., a Colleyville-based orthobiologics company specializing in magnesium-based technologies, announced that the U.S. Food and Drug Administration (FDA) has granted pediatric clearance for its Mg OSTEOCRETE and Mg OSTEOINJECT products. The clearance allows use of the technologies in pediatric patients aged six years and older.
Bone Solutions Announces Five New Patents Awarded in FY25, Further Enhancing Its Core Mg OSTEOCRETE Technology
Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced today its fifth patent awarded this year from the U.S. Patent and Trademark Office (USPTO) related to Mg OSTEOCRETE, a portfolio of patents that includes current and future configurations, as well as novel delivery systems.
Bone Solutions Receives 510(k) Clearance for Expanded Indications of Use for Mg OSTEOCRETE in Intervertebral Body Fusion Procedures
Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced today 510(k) clearance of Mg OSTEOCRETE from the U.S. Food and Drug Administration (FDA) for use in the intervertebral body disc space, including cervical, thoracic, and lumbar fusion procedures. This marks the first and only magnesium-based bone substitute to be cleared by the FDA for this application.
Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications
Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today that it has received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT. Mg OSTEOINJECT is the first drillable, adhesive, and injectable bone void filler in the U.S. to incorporate magnesium, a critical component for bone health and development.
Bone Solutions Inc. Receives FDA Clearance for Mg OSTEOREVIVE Spine Magnesium-Based Bone Void Filler
Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX announced today that it has received 510(k) clearance from the FDA for Mg OSTEOREVIVE, a magnesium-based injectable and moldable bone void filler indicated for posterolateral spine fusion procedures.
Bone Solutions Launches Mg OSTEOINJECT Injectable Magnesium-Based Bone Void Filler
Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today the immediate commercial launch of Mg OSTEOINJECT, the first injectable bone void filler in the U.S. to incorporate magnesium - a critical component for bone health and development. This flowable product is designed to promote bone repair and regeneration within insufficiency and micro fractures.
